SCHEMBL308223

SCHEMBL308223

Oc1cccc(/C=C/c2cccc(O)c2O)c1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.65
IAPP P10997 4/20 0.63
POLB P06746 4/20 0.62
GAA P10253 4/20 0.62
RAB9A P51151 1/20 0.62
RELA Q04206 1/20 0.60
ALDH1A1 P00352 3/20 0.58
HPGD P15428 2/20 0.58
ALOX15 P16050 2/20 0.58
HSD17B10 Q99714 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
LMNA P02545 2/20 0.58
RECQL P46063 2/20 0.58
ADAMTS4 O75173 1/20 0.58
EGFR P00533 1/20 0.58
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
FYN P06241 1/20 0.58
MMP2 P08253 1/20 0.58
MMP9 P14780 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21684 0.93 TRPA1 (0.61) ERN1IAPPPOLBGAARAB9A
SCHEMBL3237524 0.91 ERN1 (0.56) ERN1IAPPPOLBGAARAB9A
SCHEMBL717978 0.87 TRPA1 (0.73) ERN1IAPPPOLBGAARAB9A
SCHEMBL30279756 0.87 TRPA1 (0.73) ERN1IAPPPOLBGAARAB9A
SCHEMBL9743428 0.87 TRPA1 (0.73) ERN1IAPPPOLBGAARAB9A
SCHEMBL9251021 0.85 IAPP (0.60) ERN1IAPPPOLBGAARAB9A
SCHEMBL9251009 0.85 IAPP (0.60) ERN1IAPPPOLBGAARAB9A
SCHEMBL9745412 0.85 IAPP (0.60) ERN1IAPPPOLBGAARAB9A
SCHEMBL29149776 0.85 ERN1 (0.56) ERN1IAPPPOLBGAARAB9A
SCHEMBL5820790 0.82 CDK4 (0.70) ERN1IAPPPOLBGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024238399-A1 METHODS OF MANUFACTURING ADENO-ASSOCIATED VIRAL VECTORS SIREN BIOTECHNOLOGY, INC. (US) 2024-11-21 WO claimed
EP-4427758-A1 NEW SYNERGISTIC ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIBACTERIAL ASSOCIATION NOOS S.r.l. (IT) 2024-09-11 EP claimed
US-20230141224-A1 FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) FIGENE, LLC 2023-05-11 US claimed
EP-4142751-A1 FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Figene, LLC (US) 2023-03-08 EP claimed
CN-115616095-A Method for measuring multi-component content of Xintong oral liquid 鲁南厚普制药有限公司 2023-01-17 CN claimed
CN-113406241-B Detection method of Xintong granules 鲁南制药集团股份有限公司 2022-09-13 CN claimed
CN-114796470-A Resveratrol compound and CAR-T cell targeting NKG2D ligand combined preparation of medicine for treating malignant tumor 深圳宾德生物技术有限公司 2022-07-29 CN claimed
CN-114628056-A Light cable for railway vehicle and preparation method thereof 刘金兰 2022-06-14 CN claimed
WO-2021202032-A1 FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) FIGENE, LLC (US) 2021-10-07 WO claimed
CN-111101282-B Eight-comb sanded flannel fabric 常熟市欣鑫经纬编有限公司 2021-08-03 CN claimed
EP-1221949-A2 METHOD AND COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH COLD AND INFLUENZA-LIKE ILLNESSES THE PROCTER & GAMBLE COMPANY (US) 2002-07-17 EP claimed
EP-1207907-A2 COMPOSITIONS FOR TREATING VIRAL INFECTIONS, AND METHODS THEREFOR UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2002-05-29 EP claimed
EP-1117394-A1 COMBINATION OF CARNITINES AND RESVERATROL FOR PREVENTION OR TREATMENT OF CEREBRAL AND AGEING DISORDERS Sigma-Tau Healthscience S.p.A. (IT) 2001-07-25 EP claimed
CN-1303858-A Tetrahydroxydiphenylethylene glycosides compounds for preventing and curing angiocardiopathy and cerebrovascular diseases NO 2 MILITARY MEDICAL COLLEGE (CN) 2001-07-18 CN claimed
WO-2001021165-A1 RESVERATROL ANALOGS FOR PREVENTION OF DISEASE RUTGERS, THE STATE UNIVERSITY (US) 2001-03-29 WO claimed
WO-2001012228-A2 COMPOSITIONS FOR TREATING VIRAL INFECTIONS, AND METHODS THEREFOR UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2001-02-22 WO claimed
WO-2001008671-A2 METHOD AND COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH COLD AND INFLUENZA-LIKE ILLNESSES THE PROCTER & GAMBLE COMPANY (US) 2001-02-08 WO claimed
WO-2000021526-A1 COMBINATION OF CARNITINES AND RESVERATROL FOR PREVENTION OR TREATMENT OF CEREBRAL AND AGEING DISORDERS SIGMA-TAU HEALTHSCIENCE S.P.A. (IT) 2000-04-20 WO claimed
US-5747536-A ATHERIOSCLEROSIS AND CARDIOVASCULAR DISORDERS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1998-05-05 US claimed
EP-0773020-A2 Pharmaceutical compositions containing L-carnitine or derivatives thereof in combination with resveratrol or derivatives thereof, for the prophylaxis and treatment of cardiovascular disorders, peripheral vascular diseases and peripheral diabetic neuropathy Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1997-05-14 EP claimed